31 studies found for:    " December 04, 2013":" January 03, 2014"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 04, 2013":" January 03, 2014"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: ATV;   Drug: DRV;   Drug: Cobicistat;   Drug: BR
2 Not yet recruiting ART and Inflammatory and Coagulation Biomarkers
Conditions: HIV (Human Immunodeficiency Virus);   AIDS (Acquired Immune Deficiency Syndrome);   Tuberculosis;   Non-communicable Diseases (NCD)
Intervention:
3 Recruiting Enhanced HIV Prevention in Couples: Feasibility Study #3
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Intervention: Other: HIV Self-testing with Standard Counseling and Testing (SCT) Confirmation
4 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
Intervention:
5 Completed Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults
Conditions: HIV Infection;   Pneumococcal Infections
Intervention: Biological: pneumococcal conjugate 13 valent vaccine
6 Active, not recruiting Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
7 Not yet recruiting Gonorrhea and Chlamydia HIV-infected Men Who Have Sex With Men
Conditions: HIV Infection;   Chlamydia;   Gonorrhea
Intervention:
8 Available Compassionate Use of Dolutegravir and Ibalizumab for the Treatment of HIV Infection
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Dolutegravir;   Drug: Ibalizumab
9 Recruiting Assessment of Group Peer Support to Children With HIV in Vietnam
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Behavioral: Enhanced Treatment Support (ETS)
10 Completed
Has Results
Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa
Condition: Human Immunodeficiency Virus
Interventions: Other: Clinically Driven Monitoring (CDM);   Other: Laboratory plus Clinical Monitoring (LCM);   Drug: Arm A: ABC+3TC+NNRTI;   Drug: Arm B: ZDV+ABC+3TC+NNRTI->ABC+3TC+NNRTI maintenance;   Drug: Arm C: ZDV+ABC+3TC+NNRTI->ZDV+ABC+3TC maintenance;   Drug: Once-daily ABC+3TC;   Drug: Twice-daily ABC+3TC;   Drug: Continued cotrimoxazole prophylaxis;   Other: Stopped cotrimoxazole prophylaxis
11 Not yet recruiting Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: BMS-936559;   Drug: Placebo for BMS-936559
12 Recruiting The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia
Condition: HIV Infection
Intervention: Other: Peer‐referral incentive program to increase VMMC uptake
13 Not yet recruiting Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers
Condition: HIV Infection
Interventions: Biological: LIPO-5;   Biological: MVA HIV-B (MVATG17401);   Biological: GTU®-MultiHIV B: 0.5 mL IM via Biojector® 2000 and 0.5mL IntraDermic, 3 shots
14 Recruiting Third Line Antiretroviral Threatment Optimization in Sub-Saharan Africa
Condition: HIV Infection
Interventions: Behavioral: adherence reinforcement;   Drug: Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)
15 Recruiting Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay
Condition: HIV-1 Infection
Intervention:
16 Active, not recruiting Healthy Options: Group Psychotherapy for HIV-positive Depressed Perinatal Women.
Condition: Depression
Interventions: Behavioral: Task-sharing approach to group therapy;   Behavioral: Enhanced standard of care
17 Recruiting A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS
Condition: HIV
Intervention: Behavioral: Peer Mentoring
18 Recruiting Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa
Condition: HIV
Interventions: Other: POC CD4 Testing;   Other: CD4 Referral;   Behavioral: Lay Counselor Follow-up;   Behavioral: Clinic Accompaniment;   Behavioral: Clinic Referral;   Behavioral: SMS Reminder;   Behavioral: Circumcision Promotion;   Other: POC VL;   Other: Laboratory based VL assay
19 Not yet recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
20 Recruiting A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
Conditions: Healthy;   HIV
Interventions: Biological: 1 mg/kg, single dose IV administration of 3BNC117;   Biological: 3 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, single dose IV administration of 3BNC117

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years